Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.
about
Characterization of Δ7/11, a functional prolactin-binding proteinPhosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnoverHigh expression of prolactin receptor is associated with cell survival in cervical cancer cells.Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.An improved PSO algorithm for generating protective SNP barcodes in breast cancerEndocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine SocietyExpression of multidrug resistance proteins in invasive ductal carcinoma of the breastProtective effect of prolactin against methylmercury-induced mutagenicity and cytotoxicity on human lymphocytesUbiquitination-dependent regulation of signaling receptors in cancer.Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.Lactogens and estrogens in breast cancer chemoresistance.Drug transporter-independent liver cancer cell killing by a marine steroid methyl spongoate via apoptosis induction.Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells.STAT3 activation is required for the antiapoptotic effects of prolactin in cervical cancer cells.Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.Prolactin gene expression in primary central nervous system tumors.Liposomes containing (-)-gossypol-enriched cottonseed oil suppress Bcl-2 and Bcl-xL expression in breast cancer cells.Estrogen receptor β isoform 5 confers sensitivity of breast cancer cell lines to chemotherapeutic agent-induced apoptosis through interaction with Bcl2L12.Hypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specific.Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response.Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.Involvement of miR-106b in tumorigenic actions of both prolactin and estradiolPregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice.Breast carcinomas with hyperprolactinemia at the time of diagnosis-clinico-biological association.Co-delivery of doxorubicin and arsenite with reduction and pH dual-sensitive vesicle for synergistic cancer therapy.Stromal-epithelial interactions modulate cross-talk between prolactin receptor and HER2/Neu in breast cancer.Preventing breast cancer in women with schizophrenia.Detecting Disease Specific Pathway Substructures through an Integrated Systems Biology Approach.17β-Estradiol and ICI182,780 Differentially Regulate STAT5 Isoforms in Female Mammary Epithelium, With Distinct Outcomes.
P2860
Q24300561-410878D0-91BA-4AAE-8618-33448E45352FQ27319440-EF141669-86B4-4E25-AF30-6A8DF46097F3Q33591458-2A5ED5E1-BF7E-430C-99B1-318802DF2001Q34258777-066C5F8A-35E5-4E6B-A58E-6078D2C3C966Q34279774-CCC63B95-2F89-42C0-ACF6-2E0B192C6ED9Q34284155-9577897E-F99F-4002-9CC5-3C53A8B8C687Q34293229-39CBDA41-9BDE-43A5-B39C-13C933565CBDQ34348358-E7FDA0A3-3ED6-445C-A2AB-F443D76AE62BQ34365210-87F2380F-1316-4E20-9ED5-B77B8EED0E0BQ34994336-423A739D-F05C-4BFB-9082-2F066E9631EDQ35075176-031BEF6B-9FBE-41BC-B316-81F304AEC9E6Q35128174-3F8872CC-B294-4EC2-892F-83F2ADA867DCQ35165105-D947072E-5829-40DA-B0EB-78778D6BDE0DQ36027269-ED67DD8A-7DB4-47C3-879B-28F9296E324FQ36273402-9A07A188-EDAB-4FAA-BD47-8F5A470E38A4Q36556489-F6FE6AD9-7B0D-43EE-AFC8-3F647B7CA79DQ37257494-33AB9881-6173-491F-BB72-2C71F7875EA4Q37382513-21C8AD62-B0C0-429F-9C8A-40771D2AAB04Q37957807-8FFFF95C-E58E-420D-813F-BF637C6130CFQ38039759-C9AE673D-7261-4BB8-AC93-3CE727ACD93CQ38538492-AEC63C4C-7A69-4E11-BD02-DDAC430C223CQ38706936-9447FF6E-F5A1-4D8B-B371-1AF744D8D3EAQ39508679-EEC31012-A21E-4221-8B1D-1D461689D4A2Q43706172-A8292D62-01D0-4834-86F7-C07E7DCC800AQ50895514-A3C35CD3-2E09-4C5C-91A1-BE680BFF9CE2Q51365910-AF0A461D-5821-4D5F-9DF5-6B651255AA4AQ51832889-5C2CFCD0-B1D7-445F-9A55-4BE1EEB7C91FQ54941802-CE1A09F2-51C0-4C95-868E-4148C7963031Q55248584-297E26C6-4CBD-41C8-8D27-E9B0673DF7C5
P2860
Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.
@en
Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.
@nl
type
label
Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.
@en
Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.
@nl
prefLabel
Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.
@en
Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.
@nl
P356
P1476
Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.
@en
P2093
Elizabeth W LaPensee
P304
P356
10.1677/ERC-09-0253
P577
2010-02-25T00:00:00Z